Diagnosis of latent tuberculosis: Can we do better?

Annals of Thoracic Medicine

Volumn 4, Issue 1, 2009, Pages 5-9

  Al Orainey, Ibrahim ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Latent; Tuberculin test; Tuberculosis

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; GAMMA INTERFERON;

ANALYTIC METHOD; ASSAY; BCG VACCINATION; CELL STIMULATION; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; HUMAN; IMMUNOCOMPROMISED PATIENT; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTION; PROTEIN SECRETION; REVIEW; T LYMPHOCYTE; TUBERCULIN TEST;

EID: 58149489663     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.44778     Document Type: Review

References (47)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement, Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country, WHO Global Surveillance and Monitoring Project. J Am Med Assoc 1999;282:677-86.
2. Ferebee SH, Mount FW, Murray FJ, Livesay VT. A controlled trial of isoniazid prophylaxis in mental institutions. Am Rev Respir Dis 1963;88:161-75.
3. Styblo K. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 1980;20:1-63.
4. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47.
5. Comstock GW, Edwards LB, Livesay VT. Tuberculosis morbidity in the US Navy: Its distribution and decline. Am Rev Respir Dis 1974;110:571-80.
6. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
7. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002;57:804-9.
8. Kwamanga DO, Swai OB, Agwanda R, Githui W. Effect of nontuberculous Mycobacteria infection on tuberculin results among primary school children in Kenya. East Afr Med J 1995;72:222-7.
9. Comstock GW. False tuberculin test results. Chest 1975;68:465-9.
10. Menzies RI, Vissandjee B. Effect of bacilli Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992;145:621-5.
11. Lifschitz M. The value of the tuberculin skin test as a screening test for tuberculosis among BCG-vaccinated children. Pediatrics 1965;36:624-7.
12. Horwitz O, Bunch-Christensen K. Correlation between tuberculin sensitivity after 2 months and 5 years among BCG vaccinated subjects. Bull World Health Organ 1972;47:49-58.
13. Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F. Influence of Bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction to what size? Clin Infect Dis 2005;40:211-7.
14. Sepulveda R, Ferrer X, Latrach C, Sorensen R. The influence of Calmette-Guerin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990;142:24-8.
15. Magnus K, Edwards L. The effect of repeated tuberculin testing on post-vaccination allergy. Lancet 1955;24:643-4.
16. Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, et al. Tuberculin and energy testing in HIV-seropositive and HIV-seronegative persons: Pulmonary complications of HIV infection study group. Ann Intern Med 1993;119:185-93.
17. Chaparas SD, Vandiviere HM, Melvin I, Koch G, Becker C. Tuberculin test: Variability with the Mantoux procedure. Am Rev Respir Dis 1985;132:175-7.
18. Stuart RL, Bennett N, Forbes A, Grayson ML. A paired comparison of tuberculin skin test results in health care workers using 5 TU and 10 TU tuberculin. Thorax 2000;55:693-5.
19. National Collaborating Centre for Chronic Conditions. Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians; 2006.
20. Lein AD, Von Reyn CF. In vitro cellular and cytokine responses to mycobacterial antigens: Application to diagnosis of tuberculosis infection and assessment of response to mycobacterial vaccines. Am J Med Sci 1997;313:364-71.
21. Pottumarthy S, Morris AJ, Harrison AC, Wells VC. Evaluation of the tuberculin gamma interferon assay: Potential to replace the Mantoux skin test. J Clin Microbiol 1999;37:3229-32.
22. Streeton JA, Desem N, Jones SL. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis 1998;2:443-50.
23. Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, Shastri JS, et al. Enumeration of T-cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001;183:469-77.
24. Liu XQ, Dosanjh D, Varia H, Ewer K, Cockle P, Pasvol G, et al. Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun 2004;72:2574-81.
25. T Spot TB-Oxford Immunotec Limited. Available from: http://www. oxfordimmunotec.com/products.htm. [cited in 2004].
26. Clinicians Guide to Quantiferon-TB Gold. Available from: http://www.cellestis.com/IRM/contentAU/gold/cliniciansguide.pdf. [cited in 2004].
27. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: An interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004;170:59-64.
28. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, et al. Discrepancy between the tuberculin skin test and the whole-blood Interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756-61.
29. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clinical Reevaluation of the QuantiFERON TB-2G Test as a diagnostic method for differentiating active Tuberculosis from non-tuberculous Mycobacteriosis. Clin Infect Dis 2006;43:1540-6.
30. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001;163:824-8.
31. Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles H, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific Tcells. AIDS 2002;16:2285-93.
32. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, et al. Direct ex vivo analysis of antigen -specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis infected individuals: Associations with clinical disease state and effect of treatment. J Immunol 2001;167:5217-25.
33. Brock I, Weldingh K, Leyten EM, Arend SM, Ravn P, Andersen P. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 2004;42:2379-87.
34. Ravn P, Munk ME, Andersen AB. The diagnostic potential of the Quantiferon-RD1 test in patients with active tuberculosis. Clin Microbiol Infect 2004;10:80.
35. Menzies D, PaiComstock G. Meta-analysis: New tests for the diagnosis of latent tuberculousis infection: Areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-54.
36. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, et al. Comparison of T-cell based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168-73.
37. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001;357:2017-21.
38. Nakaoka H, Lawson L, Squire SB, Coulter B, Ravn P, Brock I, et al. Risk for tuberculosis among children. Emerg Infect Dis 2006;12:1383-8.
39. Brock I, Weldingh K, Lilleback T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004;170:65-9.
40. Shams H, Weis SE, Klucar P, Lalvani A, Moonan PK, Pogoda JM, et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005;172:1161-8.
41. Zellweger JP, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P. Contact tracing using a new T-cell based test: Better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 2005;9:1242-7.
42. Hill PC, Brookes RH, Adetifa IM, Fox A, Jackson-Sillah D, Lugos MD, et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 2006;117:1542-8.
43. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole-blood IFN-y assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008;177:1164-70.
44. Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Rawn P. Latent tuberculosis in HIV positive, diagnosed by the M. Tuberculosis. Specific Interferon Gamma test. Respir Res 2006;7:56.
45. Higuchi K, Harada N, Mori T, Sekiya Y. Use of Quantiferon-TB Gold to investigate tuberculosis contacts in a high school. Respirology 2007;12:88-92.
46. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection. United States. MMWR Recomm Rep 2005;54:49-55.
47. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole-blood IFN-y assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 2008;177:1164-70.